A Phase 2b Open-label, Randomized Two-arm Study of Selinexor (KPT-330) with Low Dose Dexamethasone in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): SADAL: Selinexor and Dexamethasone in Aggressive Lymphoma

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Karyopharm

Protocol Number
KCP-330-009

To Learn More Call
201-510-0910